Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06286267
Other study ID # SYSKY-2023-351-02
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2023
Est. completion date December 31, 2027

Study information

Verified date February 2024
Source Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Contact Yan Nie, Prof.Dr.
Phone +86 020-81332587
Email nieyan7@mail.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Breast phyllodes tumor (PT) is a rare fibroepithelial tumor, accounting for 1% to 3% of all breast tumors, categorized by the WHO into benign, borderline, and malignant, based on histopathology features such as tumor border, stromal cellularity, stromal atypia, mitotic activity and stromal overgrowth. Malignant PTs account for 18%-25%, with high local recurrence (up to 65%) and distant metastasis rates (16%-25%). Benign PT could progress to malignancy after multiple recurrences. Therefore, Early, accurate diagnosis and identification of therapeutic targets are crucial for improving outcomes and survival rates. In recent years, there has been growing interest in the application of artificial intelligence (AI) in medical diagnostics. AI can integrate clinical information, histopathological images, and multi-omics data to assist in pathological and clinical diagnosis, prognosis prediction, and molecular profiling.AI has shown promising results in various areas, including the diagnosis of different cancers such as colorectal cancer, breast cancer, and prostate cancer. However, PT differs from breast cancer in diagnosis and treatment approach. Therefore, establishing an AI-based system for the precise diagnosis and prognosis assessment of PT is crucial for personalized medicine. The research team, led by Dr. Nie Yan, is one of the few in Guangdong Province and even nationally, specializing in PT research. Their team has been conducting research on the malignant progression, metastasis mechanisms, and molecular markers for PT. The team has identified key mechanisms, such as fibroblast-to-myofibroblast differentiation, and the role of tumor-associated macrophages in promoting this differentiation. They have also identified molecular markers, including miR-21, α-SMA, CCL18, and CCL5, which are more accurate in predicting tumor recurrence risk compared to traditional histopathological grading. The project has collected high-quality data from nearly a thousand breast PT patients, including imaging, histopathology, and survival data, and has performed transcriptome gene sequencing on tissue samples. They aim to build a comprehensive multi-omics database for breast PT and create an AI-based model for early diagnosis and prognosis prediction. This research has the potential to improve the diagnosis and treatment of breast PT, address the disparities in breast PT care across different regions in China, and contribute to the development of new therapeutic targets.


Recruitment information / eligibility

Status Recruiting
Enrollment 4000
Est. completion date December 31, 2027
Est. primary completion date December 31, 2027
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Patients diagnosed with a phyllodes tumor of the breast Exclusion Criteria: - Blurred images, imaging artifacts

Study Design


Intervention

Diagnostic Test:
imaging
Patient medical imaging materials including ultrasound, mammography, CT, MRI

Locations

Country Name City State
China Guangdong Maternal and Child Health Hospital Guangzhou Guangdong
China Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou Guangdong
China Sun Yat-sen University Cancer Center Guangzhou Guangdong
China The Third Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong

Sponsors (5)

Lead Sponsor Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangdong Provincial Maternal and Child Health Hospital, Peking University Shenzhen Hospital, Sun Yat-sen University, The Third Affiliated Hospital of Guangzhou Medical University

Country where clinical trial is conducted

China, 

References & Publications (10)

Belkacemi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magne N, Malard Y, Lacroix M, Gutierrez C, Senkus E, Christie D, Drumea K, Lagneau E, Kadish SP, Scandolaro L, Azria D, Ozsahin M. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):492-500. doi: 10.1016/j.ijrobp.2007.06.059. Epub 2007 Oct 10. — View Citation

Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology. Nat Rev Clin Oncol. 2019 Nov;16(11):703-715. doi: 10.1038/s41571-019-0252-y. Epub 2019 Aug 9. — View Citation

Cheng CL, Md Nasir ND, Ng GJZ, Chua KWJ, Li Y, Rodrigues J, Thike AA, Heng SY, Koh VCY, Lim JX, Hiew VJN, Shi R, Tan BY, Tay TKY, Ravi S, Ng KH, Oh KSL, Tan PH. Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor. Lab Invest. 2022 Mar;102(3):245-252. doi: 10.1038/s41374-021-00689-0. Epub 2021 Nov 24. — View Citation

Chow ZL, Thike AA, Li HH, Nasir NDM, Yeong JPS, Tan PH. Counting Mitoses With Digital Pathology in Breast Phyllodes Tumors. Arch Pathol Lab Med. 2020 Nov 1;144(11):1397-1400. doi: 10.5858/arpa.2019-0435-OA. — View Citation

Gong C, Nie Y, Qu S, Liao JY, Cui X, Yao H, Zeng Y, Su F, Song E, Liu Q. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors. Cancer Res. 2014 Aug 15;74(16):4341-52. doi: 10.1158/0008-5472.CAN-14- — View Citation

Kates-Harbeck J, Svyatkovskiy A, Tang W. Predicting disruptive instabilities in controlled fusion plasmas through deep learning. Nature. 2019 Apr;568(7753):526-531. doi: 10.1038/s41586-019-1116-4. Epub 2019 Apr 17. — View Citation

Mishra SP, Tiwary SK, Mishra M, Khanna AK. Phyllodes tumor of breast: a review article. ISRN Surg. 2013;2013:361469. doi: 10.1155/2013/361469. Epub 2013 Mar 20. — View Citation

Nie Y, Chen J, Huang D, Yao Y, Chen J, Ding L, Zeng J, Su S, Chao X, Su F, Yao H, Hu H, Song E. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation. Cancer Res. 2017 Jul 1;77(13): — View Citation

van der Laak J, Litjens G, Ciompi F. Deep learning in histopathology: the path to the clinic. Nat Med. 2021 May;27(5):775-784. doi: 10.1038/s41591-021-01343-4. Epub 2021 May 14. — View Citation

Wang Y, Acs B, Robertson S, Liu B, Solorzano L, Wahlby C, Hartman J, Rantalainen M. Improved breast cancer histological grading using deep learning. Ann Oncol. 2022 Jan;33(1):89-98. doi: 10.1016/j.annonc.2021.09.007. Epub 2021 Sep 29. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity The probability of a positive test result, conditional on it being truly positive. Five years
Primary False-negative Rate Determine the odds of testing negative in a positive population. Five years
Primary Specificity The probability of a negative test result conditional on a true negative. Five years
Primary False-positive Rate Determine the odds of testing positive in a negative population. Five years
Primary Receiver Operating Characteristic Curve The ROC curve is a curve based on a series of different dichotomous classifications (cut-off values or decision thresholds), with the rate of true positives (sensitivity) as the vertical coordinate and the rate of false positives (1-specificity) as the horizontal coordinate. Five years
Primary Area under roc Curve AUC is defined as the area under the ROC curve enclosed with the axes, and the closer the AUC is to 1.0, the more authentic the assay is. Five years
See also
  Status Clinical Trial Phase
Completed NCT04589078 - Polyp REcognition Assisted by a Device Interactive Characterization Tool - The PREDICT Study
Completed NCT03857438 - Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania
Completed NCT04735055 - Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
Not yet recruiting NCT05452993 - Screening for Diabetic Retinopathy in Pharmacies With Artificial Intelligence Enhanced Retinophotography N/A
Not yet recruiting NCT04337229 - Evaluation of Comfort Behavior Levels of Newborns With Artificial Intelligence Techniques N/A
Completed NCT05687318 - A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment N/A
Recruiting NCT06051682 - Optimization of the Diagnosis of Bone Fractures in Patients Treated in the Emergency Department by Using Artificial Intelligence for Reading Radiological Images in Comparison With Traditional Reading by the Emergency Doctor. N/A
Not yet recruiting NCT06039917 - Effect of the Automatic Surveillance System on Surveillance Rate of Patients With Gastric Premalignant Lesions N/A
Not yet recruiting NCT06362629 - AI App for Management of Atopic Dermatitis N/A
Recruiting NCT06059378 - Real-life Implementation of an AI-based Optical Diagnosis N/A
Recruiting NCT06164002 - A I in the Prediction of Clinical Performance, Marginal Fit and Fracture Resistance of Vertical Versus Horizontal Margin Designs Fabricated With 2 Ceramic Materials N/A
Completed NCT05517889 - Repeatability and Stability of Healthy Skin Features on OCT
Completed NCT05006092 - Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE) N/A
Completed NCT04816981 - AI-EBUS-Elastography for LN Staging N/A
Recruiting NCT04535466 - Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
Enrolling by invitation NCT04719117 - Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
Completed NCT04399590 - Comparing the Number of False Activations Between Two Artificial Intelligence CADe Systems: the NOISE Study
Recruiting NCT04126265 - Artificial Intelligence-assisted Colonoscopy for Detection of Colon Polyps N/A
Recruiting NCT06255808 - Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor
Recruiting NCT04131530 - Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence